193 related articles for article (PubMed ID: 17194744)
1. Activation of liver X receptors and retinoid X receptors induces growth arrest and apoptosis in insulin-secreting cells.
Wente W; Brenner MB; Zitzer H; Gromada J; Efanov AM
Endocrinology; 2007 Apr; 148(4):1843-9. PubMed ID: 17194744
[TBL] [Abstract][Full Text] [Related]
2. Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells.
Norata GD; Ongari M; Uboldi P; Pellegatta F; Catapano AL
Int J Mol Med; 2005 Oct; 16(4):717-22. PubMed ID: 16142410
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling.
Yoshikawa T; Ide T; Shimano H; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Yatoh S; Kitamine T; Okazaki H; Tamura Y; Sekiya M; Takahashi A; Hasty AH; Sato R; Sone H; Osuga J; Ishibashi S; Yamada N
Mol Endocrinol; 2003 Jul; 17(7):1240-54. PubMed ID: 12730331
[TBL] [Abstract][Full Text] [Related]
4. Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.
Green CD; Jump DB; Olson LK
Endocrinology; 2009 Jun; 150(6):2637-45. PubMed ID: 19228891
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
[TBL] [Abstract][Full Text] [Related]
6. Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines.
Meng ZX; Yin Y; Lv JH; Sha M; Lin Y; Gao L; Zhu YX; Sun YJ; Han X
Diabetologia; 2012 Jun; 55(6):1733-44. PubMed ID: 22415588
[TBL] [Abstract][Full Text] [Related]
7. LXR activation causes G1/S arrest through inhibiting SKP2 expression in MIN6 pancreatic beta cells.
Li Y; Jing C; Tang X; Chen Y; Han X; Zhu Y
Endocrine; 2016 Sep; 53(3):689-700. PubMed ID: 27071658
[TBL] [Abstract][Full Text] [Related]
8. Palmitic acid-induced apoptosis in pancreatic β-cells is increased by liver X receptor agonist and attenuated by eicosapentaenoate.
Liang H; Zhong Y; Zhou S; Li QQ
In Vivo; 2011; 25(5):711-8. PubMed ID: 21753123
[TBL] [Abstract][Full Text] [Related]
9. Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes.
Zhang-Gandhi CX; Drew PD
J Neuroimmunol; 2007 Feb; 183(1-2):50-9. PubMed ID: 17175031
[TBL] [Abstract][Full Text] [Related]
10. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells.
Murthy S; Born E; Mathur SN; Field FJ
J Lipid Res; 2002 Jul; 43(7):1054-64. PubMed ID: 12091489
[TBL] [Abstract][Full Text] [Related]
11. Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis.
Valledor AF; Hsu LC; Ogawa S; Sawka-Verhelle D; Karin M; Glass CK
Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17813-8. PubMed ID: 15601766
[TBL] [Abstract][Full Text] [Related]
12. Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic beta-cells.
Efanov AM; Sewing S; Bokvist K; Gromada J
Diabetes; 2004 Dec; 53 Suppl 3():S75-8. PubMed ID: 15561926
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptors (LXRs) regulate apolipoprotein AIV-implications of the antiatherosclerotic effect of LXR agonists.
Liang Y; Jiang XC; Liu R; Liang G; Beyer TP; Gao H; Ryan TP; Dan Li S; Eacho PI; Cao G
Mol Endocrinol; 2004 Aug; 18(8):2000-10. PubMed ID: 15131258
[TBL] [Abstract][Full Text] [Related]
14. Sterol regulatory element-binding protein 1 mediates liver X receptor-beta-induced increases in insulin secretion and insulin messenger ribonucleic acid levels.
Zitzer H; Wente W; Brenner MB; Sewing S; Buschard K; Gromada J; Efanov AM
Endocrinology; 2006 Aug; 147(8):3898-905. PubMed ID: 16644917
[TBL] [Abstract][Full Text] [Related]
15. Global analysis of nuclear receptor expression and dysregulation in human osteoarthritic articular cartilage: reduced LXR signaling contributes to catabolic metabolism typical of osteoarthritis.
Collins-Racie LA; Yang Z; Arai M; Li N; Majumdar MK; Nagpal S; Mounts WM; Dorner AJ; Morris E; LaVallie ER
Osteoarthritis Cartilage; 2009 Jul; 17(7):832-42. PubMed ID: 19217805
[TBL] [Abstract][Full Text] [Related]
16. Activation of liver X receptors inhibits pancreatic islet beta cell proliferation through cell cycle arrest.
Meng ZX; Nie J; Ling JJ; Sun JX; Zhu YX; Gao L; Lv JH; Zhu DY; Sun YJ; Han X
Diabetologia; 2009 Jan; 52(1):125-35. PubMed ID: 18949453
[TBL] [Abstract][Full Text] [Related]
17. LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms.
Verschuren L; de Vries-van der Weij J; Zadelaar S; Kleemann R; Kooistra T
J Lipid Res; 2009 Feb; 50(2):301-11. PubMed ID: 18757914
[TBL] [Abstract][Full Text] [Related]
18. The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver.
Sabol SL; Brewer HB; Santamarina-Fojo S
J Lipid Res; 2005 Oct; 46(10):2151-67. PubMed ID: 16024918
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte fatty acid-binding protein (aP2), a newly identified LXR target gene, is induced by LXR agonists in human THP-1 cells.
Liu QY; Quinet E; Nambi P
Mol Cell Biochem; 2007 Aug; 302(1-2):203-13. PubMed ID: 17396233
[TBL] [Abstract][Full Text] [Related]
20. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
